Table 1.
IL-4, IL-6, IL-10, IL-12, IL-17, IL-23, TNF-α, IFN-γ and TGF-β content
| Index | Control (n = 9) | EAE (n = 9) | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| 7 D | 18 D | 30 D | 7 D | 18 D | 30 D | |
| IL-4 (pg/mL) | 128.34±34.18 | 154.22±35.28 | 126.78±36.24 | 158.75±37.15* | 135.28±17.43 | 120.44±28.17 |
| IL-6 (pg/mL) | 98.43±5.49 | 101.20±6.75 | 96.62±3.89 | 108.80±6.16* | 100.19±6.75 | 99.90±5.04 |
| IL-10 (pg/mL) | 370.12±26.47 | 505.21±70.50 | 459.08±38.61 | 492.21±74.58* | 456.70±69.24 | 424.46±81.63 |
| IL-12 (pg/mL) | 52.25±5.40 | 60.03±7.31 | 54.34±7.61 | 53.59±12.89 | 49.31±10.93* | 51.39±4.84 |
| IL-17 (pg/mL) | 6.72±0.35 | 6.80±0.52 | 6.25±0.32 | 7.06±0.68 | 6.03±1.48* | 6.14±0.39 |
| IL-23 (pg/mL) | 73.19±8.19 | 84.47±8.80 | 76.65±4.33 | 82.49±9.42* | 75.90±6.38* | 75.24±4.70 |
| TNF-α (pg/mL) | 474.50±106.31 | 469.35±70.83 | 493.16±68.21 | 600.15±83.04* | 445.18±106.88 | 503.62±81.71 |
| IFN-γ (pg/mL) | 598.18±45.39 | 809.23±83.42 | 690.50±49.21 | 765.26±106.05* | 674.42±90.87* | 681.22±68.39 |
| TGF-β (pg/mL) | 732.48±130.48 | 1002.99±46.11 | 961.35±128.67 | 958.41±205.15* | 868.99±115.90* | 814.59±94.19* |
*
P<0.05 vs. Control.